Related Experiment Video

Updated: May 31, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

MicroRNA expression and clinical outcome of small cell lung cancer

Jih-Hsiang Lee1, Johannes Voortman, Anne-Marie C Dingemans

  • 1Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

Plos One
|July 7, 2011
PubMed

Insights

MicroRNAs, including miR-34a, are not prognostic in small-cell lung carcinoma (SCLC). This study found miR-34a is unrelated to SCLC cell behavior and unlikely to be a therapeutic target for this cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play crucial roles in various cancers, but their function in small-cell lung carcinoma (SCLC) remains largely unexplored.
  • miR-34a, a known tumor suppressor miRNA regulated by p53, has potential therapeutic implications, yet its role in SCLC, characterized by frequent p53 dysfunction, is unstudied.

Purpose of the Study:

  • To investigate the expression of seven key microRNAs (miR-21, miR-29b, miR-34a/b/c, miR-155, and let-7a) in SCLC.
  • To determine the prognostic and predictive value of these miRNAs in SCLC patients.
  • To assess the therapeutic potential of miR-34a in SCLC by examining its effect on cell viability and drug sensitivity.

Main Methods:

  • Quantitative analysis of miRNA expression in 31 SCLC tumors and 14 SCLC cell lines compared to 26 non-small-cell lung carcinoma (NSCLC) cell lines.
  • Correlation analysis of miRNA expression with clinical characteristics, overall survival, progression-free survival, and treatment response.
  • In vitro experiments involving overexpression and downregulation of miR-34a in SCLC cell lines to assess effects on cell viability, cisplatin, and etoposide sensitivity.

Main Results:

  • Significantly lower expression of miR-21, miR-29b, and miR-34a was observed in SCLC cell lines compared to NSCLC cell lines.
  • miRNA expression levels did not correlate with SCLC patient clinical characteristics, survival outcomes, or treatment response.
  • Modulating miR-34a expression did not affect SCLC cell viability or sensitivity to cisplatin or etoposide; target genes cMET and Axl showed low intrinsic expression in SCLC.

Conclusions:

  • The investigated microRNAs, including miR-34a, do not serve as prognostic markers in SCLC patients.
  • miR-34a is not associated with the malignant behavior of SCLC cells and is unlikely to be a viable therapeutic target for SCLC treatment.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...